Hiv infection laboratory testing-Lab Tests and | cherrycitykitties.com

HIV diagnostic testing has come a long way since its inception in the early s. Current enzyme immunoassays are sensitive enough to detect antibody as early as one to two weeks after infection. A variety of other assays are essential to confirm positive antibody screens Western blot, polymerase chain reaction [PCR] , provide an adjunct to antibody testing p24 antigen, PCR , or provide additional information for the clinician treating HIV-positive patients qualitative and quantitative PCR, and genotyping. Point of Care tests have become increasingly popular in the United States and some places in Canada over the past several years. HIV infection is identified either by the detection of HIV-specific antibodies in serum or plasma or by demonstrating the presence of the virus by nucleic acid detection using polymerase chain reaction PCR , p24 antigen testing or, rarely these days, by growing virus in cell culture.

Hiv infection laboratory testing

Hiv infection laboratory testing

Hiv infection laboratory testing

Centers for Disease Control and Prevention. Hiv infection laboratory testing ensures that physicians receive accurate and timely laboratory information to guide patient management. Specimens that screen positive in the first assay but negative in the second assay should still laboratry considered for confirmatory testing if the patient is symptomatic or high risk. While there is no cure for HIV, there are better treatments available now than in the past. Clear Turn Off Turn On. Related Cool whore generator. Western blot The Western blot is an immunoblot that allows for the characterization of antibodies to each viral Hiv infection laboratory testing. A negative result may also mean you testinf HIV but it's too soon to tell. Ver Mas Recursos.

How to make your wife obey. Laboratory Testing Guidance

Refer to www. Guidelines infsction Recommendations. Younger adolescents and older adults who are at increased risk should also be screened. Oral fluid: Society Rihana naked pics because actions can be taken to reduce HIV transmission. Laboratory testing for the diagnosis of HIV infection : updated recommendations. Guidelines and Recommendations. AIDS ;27 5 Access to care and prevention are important to maintain the health Hiv infection laboratory testing individuals at risk and to prevent transmission by those who acquire HIV. We are very grateful for feedback on the website and on your experience and would appreciate it if you would complete our brief survey. Toggle navigation. The Western blot is an immunoblot that trsting for the characterization of antibodies to each viral protein. File Format:. The appropriate tests to aid in the diagnosis of infant HIV infectioninclude 1 :. To be used in conjunction with: Hiv infection laboratory testing testing for the diagnosis of HIV infection : updated recommendations.

This guide is designed to be clicked through one screen at a time.

  • Note: Javascript is disabled or is not supported by your browser.
  • Medical Care Criteria Committee , October
  • Note: Javascript is disabled or is not supported by your browser.

This guide is designed to be clicked through one screen at a time. To see the entire lesson on a single page, go to "See all Lab Tests" in the box at right. Laboratory tests can help keep tabs on your health.

Some of these tests will be done soon after you learn you are HIV positive. Then depending on your immune status, whether you are on medication or not, and a variety of other factors, your provider will set up a schedule for you. This can help you tell how fast or slow the disease is moving and indicate whether treatments are working.

Instead look for overall trends. Search this website Submit. Veterans Crisis Line: Press 1. Complete Directory. If you are in crisis or having thoughts of suicide, visit VeteransCrisisLine. Quick Links. Just Diagnosed This guide is designed to be clicked through one screen at a time. See all Lab Tests Share this page.

Plasma can be stored frozen for three months before testing, and is stable for 24 h at room temperature. Exposure to HIV is a medical emergency that requires prompt response. External link. Early diagnosis and treatment can reduce the risk of mother-to-child transmission of HIV. Scope -- E. The CDC no longer recommends using the Western blot technique to confirm the presence of HIV-1 antibodies in repeatedly reactive specimens because:.

Hiv infection laboratory testing

Hiv infection laboratory testing

Hiv infection laboratory testing. FDA Approved HIV Tests

In contrast, fourth generation screening tests can detect HIV during a portion of this window period and afterwards, ie, during a portion of the acute phase and all of the chronic phase of the disease. This ability has substantial individual and societal benefits. Society benefits because actions can be taken to reduce HIV transmission. However, if individuals are diagnosed during the acute phase of the illness, they can be counseled regarding risk reduction practices and can reduce their viral load with antiviral medication.

Both of these actions reduce the likelihood of transmission to uninfected partners. The key concepts associated with the CDC recommendations are illustrated here.

The CDC no longer recommends using the Western blot technique to confirm the presence of HIV-1 antibodies in repeatedly reactive specimens because:. The precise reason for a false positive result in any individual specimen is not likely to be definitively known. A few of the causes hypothesized in the medical literature include recent administration of selected vaccines, presence of HLA-DR antibodies, presence of rheumatoid factors, reactive RPR, hypergammaglobulinemia, cross-reactive immune response to other exogenous and endogenous retroviruses, and autoimmune conditions.

Refer to www. This purported anecdotal association may have been due to an initially greater frequency of testing of pregnant women prior to issuance of the CDC HIV testing recommendations.

Minimizing pre-analytic sample handling issues is critical, given the clinical significance of a positive HIV test result. Healthcare providers should screen patients who engage in high-risk behavior every 3 months and should provide or refer these individuals for ongoing medical care, risk-reduction counseling and services, and HIV prevention, such as pre-exposure prophylaxis PrEP.

Access to care and prevention are important to maintain the health of individuals at risk and to prevent transmission by those who acquire HIV. According to data from the CDC [Dailey, et al. Many of these individuals did not acknowledge themselves to be at high risk. The U. Preventative Health Task Force notes that for individuals not engaged in the high-risk behavior outlined above, but are still at increased risk, a somewhat longer interval for example, 3 to 5 years may be adopted [U.

Preventive Services Task Force ]. A change in sexual partner or marital status merits repeat HIV screening. Routine rescreening may not be necessary for individuals who have not been at increased risk since they were found to be HIV-negative.

Women screened during a previous pregnancy should be rescreened in subsequent pregnancies. Is written consent required before an HIV test is ordered? As of May 17, , neither written nor oral consent is needed before ordering an HIV test; however, patients must be informed that an HIV test will be performed and they may opt out. What is the best test to use for HIV screening?

Can a rapid point-of-care test be used for HIV screening? Yes, although it will detect antibodies later in the course of HIV infection and may miss early infection in many cases. There are also newer point-of-care tests that detect antigen and, therefore, earlier infection. It is worth clarifying with your facility which rapid test is used. Yes, that is the optimal test.

As follow-up, the healthcare provider should:. In this scenario, the healthcare provider should:. The healthcare provider should also provide risk-reduction counseling e. The length of time depends on which HIV test is used. For an HIV antibody test with reflex to Western blot, there is a window period of up to 3 months updated May 28, Can a person who has HIV transmit the virus to another person during the window period?

What is acute HIV infection and when should it be considered? Clinicians should consider acute HIV infection if a patient presents with a clinical syndrome consistent with acute HIV. What are the symptoms of acute HIV infection? Symptoms of acute HIV infection are similar to those of influenza and may include fever, fatigue, malaise, joint pains, headache, loss of appetite, rash, night sweats, myalgia, nausea, diarrhea, and pharyngitis.

Which laboratory tests should be ordered for an individual who is suspected to have acute HIV? Is a person with acute HIV able to transmit the virus to others? When treating a pregnant individual who has acute HIV, should the healthcare provider consult with a specialist? If the HIV RNA test is positive or the HIV test is reactive, then, as soon as possible, the care provider should consult with or refer the patient to a clinician who is experienced in diagnosing and evaluating acute HIV infection.

PrEP should be prescribed as part of a comprehensive prevention strategy that includes risk-reduction counseling about safer sex practices, condom use, and safer injection practices, as well as referral to syringe exchange programs and drug treatment services when appropriate.

Exposure to HIV is a medical emergency that requires prompt response. How do I locate a healthcare provider with experience in treating patients with HIV, for consultation or referral? Preventive Services Task Force. We are very grateful for feedback on the website and on your experience and would appreciate it if you would complete our brief survey.

Yes, I will give feedback—take me to the survey now. For these patients, every effort should be made to initiate ART immediately, and ideally, on the same day as diagnosis.

All clinical care settings should be prepared, either on-site or with a confirmed referral, to support patients in initiating ART as rapidly as possible after diagnosis. Additional information regarding testing procedures and regulations is available from the Wadsworth Center A1 For all individuals who test negative and have recent or ongoing high-risk behavior, clinicians should discuss goal-oriented, harm-reduction strategies such as PrEP and the emergency availability of post-exposure prophylaxis PEP.

Clinicians should refer these patients as appropriate for counseling services and should offer repeat testing every 3 months, or sooner if acute HIV infection is suspected, for as long as high-risk behavior continues. Click to Enlarge HIV screening and diagnostic tests are designed to detect specific markers of infection. Consult the specimen collection and handling instructions provided by the laboratory to ensure that the specimen will be suitable for all tests in the algorithm.

When possible, blood should be collected by venipuncture and submitted to a clinical laboratory for HIV diagnostic testing. A reactive result on the initial screening test with inconclusive supplemental serologic testing may represent either a false or a true positive.

Technical errors, including: Specimen mix-up or mislabeling, in which the laboratory inadvertently switches two samples, one being positive and the other negative. Contamination, in which material from a positive sample is introduced into a negative sample as a result of mishandling, poor laboratory technique, or instrument malfunction. Influenza vaccination may cause cross-reactivity with HIV Ab assays. The time course for such cross-reactivity remains uncertain. Acute infection before seroconversion , with screening performed using a less sensitive method that detects Abs only.

Technical errors, including, for instance: Specimen mix-up or mislabeling, in which the laboratory inadvertently switches two samples, one being positive and the other negative.

Specimen mishandling, in which a positive sample is exposed to conditions that cause degradation of test analytes e. Diminished immune response in individuals receiving intensive or long-term immunosuppressive therapy. Congenital or drug-induced hypogammaglobulinemia or agammaglobulinemia. Insufficient host Ab response i. Unavailability of Abs due to the formation of Ag-Ab complexes. Rapid screening tests may be performed at either the POC or the laboratory. Nonspecific reactivity could cause an HIV-2 indeterminate result to occur in some cases.

References CDC. Data shown are for HIV-1 only. For HIV-2 data, see package inserts. Finger stick and venipuncture. References FDA. Consent Is written consent required before an HIV test is ordered? Screen for suicidality and domestic violence and make sure the patient is safe. Discuss ART initiation at the time of a positive result with the first rapid test. Initiation of ART during acute infection may have a number of beneficial clinical outcomes. The Department of Health can provide assistance if necessary.

A person who reports a potential exposure to HIV should be given a first dose of antiretroviral medications for PEP immediately ideally within 2 hours of the exposure. Guidelines are available for PEP following occupational and non-occupational exposure to HIV and following sexual assault.

Give Feedback. Thank you. Increased sensitivity of assays, leading to reduced specificity. Immunometric assay Serum, plasma Does not differentiate detection of Ag and Ab. Patients who receive a reactive HIV rapid screening test result should be informed that the test result is not a diagnosis of HIV infection and requires confirmation. Oral fluid: Fingerstick whole blood: Finger stick whole blood:

Laboratory Tests | HIV Testing | HIV/AIDS | CDC

HIV diagnostic testing has come a long way since its inception in the early s. Current enzyme immunoassays are sensitive enough to detect antibody as early as one to two weeks after infection. A variety of other assays are essential to confirm positive antibody screens Western blot, polymerase chain reaction [PCR] , provide an adjunct to antibody testing p24 antigen, PCR , or provide additional information for the clinician treating HIV-positive patients qualitative and quantitative PCR, and genotyping.

Point of Care tests have become increasingly popular in the United States and some places in Canada over the past several years. HIV infection is identified either by the detection of HIV-specific antibodies in serum or plasma or by demonstrating the presence of the virus by nucleic acid detection using polymerase chain reaction PCR , p24 antigen testing or, rarely these days, by growing virus in cell culture.

In a small number of early seroconverters who are still in the 'window period', the p24 antigen may become positive before antibody is detectable. Therefore, to enable the laboratory to select appropriate testing, it is important to provide a clinical history that includes any recent high-risk behaviour or symptoms consistent with seroconversion illness 1 - 3.

Some laboratories may use a radioimmunoprecipitation assay as their confirmatory assay or as part of their HIV testing algorithm. In a radioimmunoprecipitation assay test, radiolabelled viral proteins are reacted with the patient's serum to produce radioactive antigen-antibody complexes.

PCR is particularly useful in testing infants of HIV-positive mothers; these infants may carry maternal antibody to 15 months of age 4. It is also useful when testing patients who are agammaglobulinemic or in rare cases where patients appear to have symptoms of advanced HIV infection but do not demonstrate HIV-specific antibodies.

Aside from diagnostic HIV testing, laboratories may also offer quantitative PCR RNA testing viral load , which is used to help determine the initiation of drug therapy and monitor the effectiveness of therapy.

HIV genotyping is a newer adjunct to patient management and is used to assist in tracking the development of drug resistance and guide the modification of antiretroviral drug selection 3. Strongly positive screen test samples, which give an indeterminate or unusual HIV-1 Western blot pattern, are retested on a specific HIV-2 blot. If possible, a dedicated tube for HIV testing is preferred to minimize the possibility of cross contamination during handling.

Laboratories should provide their clients with specific guidelines on the collection and submission of samples for HIV testing locally. Performance of these assays, including p24 antigen testing, has been validated on serum and plasma. The assays have not been validated on post-mortem specimens or body fluids such as urine, saliva, semen or pleural fluid.

A number of tests designed specifically for urine, oral fluid or finger-prick specimens are in use for testing in special circumstances eg, insurance screening, population surveillance. Specimens are collected as indicated by the manufacturer. Any sample that has been previously frozen should be indicated as such because special handling may be required for some of the test kits currently in use.

For shipping to the laboratory, specimens must be packaged and labelled in compliance with Transport Canada's Transportation of Dangerous Goods regulations 6 as they apply to the shipment of clinical specimens. All clinical diagnostic specimens must be properly labelled with a patient identifier and accompanied by a completed laboratory requisition with relevant clinical information to guide appropriate test selection. Laboratories must provide clients with guidelines for the collection, storage, shipping, timing and types of tubes used for PCR testing.

These specimens generally need to be processed within 48 h of collection. Blood collection tubes may vary depending on the PCR assay being used. Do not freeze! Processing to prepare the specimen for testing must take place within 48 h of collection. Viral DNA denatures over time and becomes undetectable. Whole blood in EDTA is stable for only 4 h, while blood in PPT, if centrifuged within 4 h of collection, is stable at room temperature for 24 h.

Plasma can be stored frozen for three months before testing, and is stable for 24 h at room temperature. Only Health Canada-approved tests should be used by diagnostic laboratories in Canada. These assays are used because they are highly sensitive and generally amenable to automation, facilitating high-volume testing. Laboratories may choose to first test with a second EIA assay, which uses a different part of the viral antigen for antibody capture, as part of their testing algorithm.

Specimens that screen positive in the first assay but negative in the second assay should still be considered for confirmatory testing if the patient is symptomatic or high risk. In rare instances, the p24 antigen can be detected before HIV antibody in newly infected individuals.

A follow-up HIV antibody test should be requested when a patient is p24 antigen-positive but antibody-negative. In a seroconverting patient, the follow-up specimen will be positive within a few weeks after the initial screen. It is important to remember that not all seroconverting patients will have detectable p24 antigen, and that this antigen may not be reliably found in individuals who are known to be HIV antibody-positive.

The Western blot is an immunoblot that allows for the characterization of antibodies to each viral protein. Patient serum is reacted with a nitrocellulose strip containing all of the constitutive HIV virus proteins core and envelope , arranged by molecular weight after polyacrylamide gel electrophoresis.

Any specific antibodies present in the patient's serum will bind to the antigen, producing a coloured band when alkaline phosphatase-labelled, antihuman immunoglobulin G conjugate and colour development solution are added. These bands can be visualized, and positivity is assessed following the manufacturer's recommendations and based on the number and type of bands present.

Generally, a specimen must show a positive reaction with a minimum of one core band and one envelope band to be judged positive by Western blot. Specimens that have bands present but do not fulfill the criteria for positivity are called Western blot indeterminate, and a follow-up specimen should be requested, usually collected three to four weeks after the initial specimen.

In follow-up, patients will either show a definitive pattern indicating that they have seroconverted or will demonstrate the same banding pattern as previously observed. In the latter circumstance, the vast majority of these patients are HIV-negative and have nonspecific antibody. Because these indeterminate banding patterns may be seen in patients who are not infected, the Western blot does not make a good screening test for HIV. PCR is a method that amplifies viral nucleic acid to allow for its detection in patient specimens.

It is a particularly specific and sensitive test which can pick up very small numbers of viral particles. Babies will carry maternal antibody up to approximately 15 months of age and, therefore, the antibody test is not a reliable indicator of infection in these children. In North America, this would be a very uncommon finding. It is used in conjunction with CD4 counts and general clinical assessments to ascertain when therapy should be started.

It is also used to help determine the patient's response to therapy. Genotyping is used to monitor the development or presence of drug resistance in patients before or during therapy. It is also used to assist physicians in their choice of antiretroviral drug combinations for the patient 3 , 7.

Quantitative PCR should not be used as a diagnostic test for HIV because false positives and false negatives can occur in these circumstances. POC testing is testing carried out wherever the patient is located - in a clinic, hospital or doctor's office. The use of such testing varies across Canada, with some provinces not using it at all and others using it extensively in sexually transmitted infection clinics or hospitals and as a preliminary screen for needlestick exposures in a health care setting 8.

The basic recommendations are as follows:. These tests should be used only in sites that provide a comprehensive quality assurance program as it relates to laboratory testing, as stated below. Participation in proficiency testing is a key component of any laboratory quality assurance program, whether available locally, nationally or internationally When external proficiency programs are not available, groups of laboratories may set up their own proficiency testing program by sharing samples among themselves.

At the time of writing, the aforementioned proficiency testing programs are available free of charge to participants the only costs are reagents and staff time. QMP-LS charges out-of-province participants. This ensures that physicians receive accurate and timely laboratory information to guide patient management.

Regular audits of laboratory procedures and reviews of incident reports should be carried out by senior staff and summarized for discussion with the laboratory director 10 , An up-to-date, complete laboratory manual or manual of standard operating procedures is an important component of the quality assurance program.

The manual should be reviewed regularly by senior staff and the laboratory director, and all staff must read and be familiar with the procedures they are responsible for performing in the laboratory. Reagent and equipment performance must be monitored over time to detect any changes in quality and integrity. Routine daily, weekly and monthly equipment maintenance must be carried out as per the manufacturer's instructions.

Levy-Jennings plots should be performed on a regular basis and reviewed by a senior technologist for any aberrant values or shifts in control performance. Controls should be selected to include weak positives or borderline samples as well as those giving a strong positive and negative result on each assay used in the laboratory. On automated instruments, controls should be placed in a position to detect carry-over. Procedures to be followed when controls are out of range must be clearly described in the laboratory manual, and problems and corrective action should be documented by laboratory staff.

National Center for Biotechnology Information , U. Author information Copyright and License information Disclaimer. All rights reserved. This article has been cited by other articles in PMC. Abstract HIV diagnostic testing has come a long way since its inception in the early s. Open in a separate window. Figure 1. Diagnostic Tests Only Health Canada-approved tests should be used by diagnostic laboratories in Canada.

Western blot The Western blot is an immunoblot that allows for the characterization of antibodies to each viral protein. POC: POC testing is testing carried out wherever the patient is located - in a clinic, hospital or doctor's office. The basic recommendations are as follows: Only a Health Canada-approved device should be used. Proficiency And Quality Assurance Proficiency testing Participation in proficiency testing is a key component of any laboratory quality assurance program, whether available locally, nationally or internationally References 1.

Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. Zhang M, Versalovic J. HIV update. Diagnostic tests and markers of disease progression and response to therapy.

Canadian STD Guidelines , edn. Ottawa: Health Canada, Diagnostic detection of human immunodeficiency virus type 1 antibodies in urine: A Brazilian study. J Clin Microbiol ; 40 Transportation of Dangerous Goods Act, Clin Infect Dis ; 37

Hiv infection laboratory testing

Hiv infection laboratory testing